Clinical significance of RBC alloantibodies and autoantibodies in sickle cell patients who received transfusions

Transfusion

Volumn 42, Issue 1, 2002, Pages 37-43

  Aygun, Banu ^a,b   Padmanabhan, Savitri ^a,b   Paley, Carole ^a,b   Chandrasekaran, Visalam ^a,b  

^a SCHNEIDER CHILDREN'S HOSPITAL   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; AUTOANTIBODY;

ADOLESCENT; ADULT; ANTIBODY SPECIFICITY; AUTOIMMUNE HEMOLYTIC ANEMIA; BLOOD; BLOOD GROUP ABO SYSTEM; BLOOD GROUP INCOMPATIBILITY; BLOOD GROUP RHESUS SYSTEM; BLOOD GROUP TYPING; BLOOD TRANSFUSION; CHILD; CLINICAL TRIAL; ERYTHROCYTE MEMBRANE; FEMALE; FEVER; HEMOGLOBINOPATHY; HEMOLYTIC ANEMIA; HUMAN; HYPERSPLENISM; IMMUNIZATION; IMMUNOLOGY; INFANT; MALE; MULTICENTER STUDY; PRESCHOOL CHILD; RETROSPECTIVE STUDY; REVIEW; SICKLE CELL ANEMIA;

ABO BLOOD-GROUP SYSTEM; ADOLESCENT; ADULT; ANEMIA, HEMOLYTIC; ANEMIA, HEMOLYTIC, AUTOIMMUNE; ANEMIA, SICKLE CELL; ANTIBODY SPECIFICITY; AUTOANTIBODIES; BLOOD GROUP INCOMPATIBILITY; BLOOD GROUPING AND CROSSMATCHING; BLOOD TRANSFUSION; CHILD; CHILD, PRESCHOOL; ERYTHROCYTE MEMBRANE; FEMALE; FEVER; HEMOGLOBINOPATHIES; HUMANS; HYPERSPLENISM; IMMUNIZATION; INFANT; ISOANTIBODIES; MALE; RETROSPECTIVE STUDIES; RH-HR BLOOD-GROUP SYSTEM;

EID: 0036360040     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.2002.00007.x     Document Type: Review

References (16)

1. 1 Vichinsky EP, Earles A, Johnson RA, et al. Alloimmunization in sickle cell anemia and transfusion of racially unmatched blood. N Engl J Med 1990 ; 322: 1617 ‐ 21.
2. 2 Rosse WF, Gallagher D, Kinney TR, et al. Transfusion and alloimmunization in sickle cell disease. The Cooperative Study of Sickle Cell Disease. Blood 1990 ; 76: 1431 ‐ 7.
3. 3 Cox JV, Steane E, Cunningham G, Frenkel EP. Risk of alloimmunization and delayed hemolytic transfusion reactions in patients with sickle cell disease. Arch Intern Med 1988 ; 148: 2485 ‐ 9.
4. 4 Petz LD, Calhoun L, Shulman IA, et al. The sickle cell hemolytic transfusion reaction syndrome. Transfusion 1997 ; 37: 382 ‐ 92.
5. 5 Garratty G. Severe reactions associated with transfusion of patients with sickle cell disease (letter). Transfusion 1997 ; 37: 357 ‐ 61.
6. 6 King KE, Shirey RS, Lankiewicz MW, et al. Delayed hemolytic transfusion reactions in sickle cell disease: simultaneous destruction of recipients' red cells. Transfusion 1997 ; 37: 376 ‐ 81.
7. 7 Win N, Doughty H, Telfer P, et al. Hyperhemolytic transfusion reaction in sickle cell disease. Transfusion 2001 ; 41: 323 ‐ 8.
8. 8 Reisner EG, Kostyu DD, Phillips G, et al. Alloantibody responses in multiply transfused sickle cell patients. Tissue Antigens 1987 ; 30: 161 ‐ 6.
9. 9 Davies SC, McWilliam AC, Hewitt PE, et al. Red cell alloimmunization in sickle cell disease. Br J Haematol 1986 ; 63: 241 ‐ 5.
10. 10 Friedman DF, Lukas MB, Jawad A, et al. Alloimmunization to platelets in heavily transfused patients with sickle cell disease. Blood 1996 ; 88: 3216 ‐ 22.
11. 11 Tahhan HR, Holbrook CT, Braddy LR, et al. Antigen‐matched donor blood in the transfusion management of patients with sickle cell disease. Transfusion 1994 ; 34: 562 ‐ 9.
12. 12 Wayne AS, Kevy SV, Nathan DG. Transfusion management of sickle cell disease. Blood 1993 ; 81: 1109 ‐ 23.
13. 13 Castro O. Management of sickle cell disease: recent advances and controversies. Br J Haematol 1999 ; 107: 2 ‐ 11.
14. 14 Castellino SM, Combs MR, Zimmerman SA, et al. Erythrocyte autoantibodies in paediatric patients with sickle cell disease receiving transfusion therapy: frequency, characteristics and significance. Br J Haematol 1999 ; 104: 189 ‐ 94.
15. 15 Alarif L, Castro O, Ofosu M, et al. HLA‐B35 is associated with red cell alloimmunization in sickle cell disease. Clin Immunol Immunopathol 1986 ; 38: 178 ‐ 83.
16. 16 Sosler SD, Jilly BJ, Saporito C, Koshy M. A simple, practical model for reducing alloimmunization in patients with sickle cell disease. Am J Hematol 1993 ; 43: 103 ‐ 6.